Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00324688
What this trial is testing

Safety Study of Once a Day ART and Opiate Substitute.

Who this might be right for
HIV Infections
Gilead Sciences 60
Not applicableLooking for participantsNCT07727642
What this trial is testing

Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma

Who this might be right for
AIDS-related LymphomaHIV Infection
Shanghai Public Health Clinical Center 60
Early research (Phase 1)Active Not RecruitingNCT05646082
What this trial is testing

Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma

Who this might be right for
Refractory HIV Associated Kaposi Sarcoma
Imperial College London 15
Large-scale testing (Phase 3)Ended earlyNCT00120770
What this trial is testing

Cellulose Sulfate (CS) Gel and HIV in Nigeria

Who this might be right for
HIV InfectionsGonorrheaChlamydia Infections
FHI 360 2,160
Testing effectiveness (Phase 2)Study completedNCT00212888
What this trial is testing

Combination Vaccination Before HIV Treatment Interruption

Who this might be right for
HIV Infections
Ottawa Hospital Research Institute 52
Post-approval studies (Phase 4)Study completedNCT00117494
What this trial is testing

Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)

Who this might be right for
HyperlipidemiaHIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 86
Not applicableStudy completedNCT00130273
What this trial is testing

Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV

Who this might be right for
HIV Infections
University of Pennsylvania 180
Not applicableStudy completedNCT02514369
What this trial is testing

Pharmacogenomics of New Antiretrovirals

Who this might be right for
HIV
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 179
Not applicableStudy completedNCT03568682
What this trial is testing

Improving Antiretroviral Therapy Adherence Through Urban Gardening and Nutritional Counseling in the Dominican Republic

Who this might be right for
HIV
RAND 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT04800159
What this trial is testing

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

Who this might be right for
HIVCannabis Use
University of California, San Diego 40
Large-scale testing (Phase 3)UnknownNCT04429152
What this trial is testing

ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance

Who this might be right for
HIV-1-infection
Professor Francois Venter 25
Large-scale testing (Phase 3)WithdrawnNCT02069834
What this trial is testing

Dolutegravir + Rilpivirine Switch Study (DORISS)

Who this might be right for
HIV InfectionHAART-treatedVirologically Controlled
Nantes University Hospital
Post-approval studies (Phase 4)Study completedNCT00107887
What this trial is testing

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Who this might be right for
TuberculosisHIV Infections
Johns Hopkins University 17,415
Not applicableStudy completedNCT02304263
What this trial is testing

Tenofovir Pharmacology in Older HIV Infected Individuals

Who this might be right for
HIVAging
University of Colorado, Denver 45
Large-scale testing (Phase 3)Study completedNCT00669487
What this trial is testing

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

Who this might be right for
HIV Infections
SEARCH Research Foundation 150
Early research (Phase 1)Study completedNCT00000814
What this trial is testing

A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 390
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Testing effectiveness (Phase 2)Study completedNCT00795444
What this trial is testing

Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1

Who this might be right for
HIV-1
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Not applicableStudy completedNCT00672932
What this trial is testing

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

Who this might be right for
HIV Infections
University of California, San Francisco 18
Not applicableStudy completedNCT03059121
What this trial is testing

The Cleveland Cardiometabolic Cohort

Who this might be right for
HIVLipodystrophy
University Hospitals Cleveland Medical Center 56
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation